Clinical Trials in Pittsburgh

Showing 18761-18780 of 21,047 trials

Pharmacological Intervention Project (Fluoxetine)

NCT00027378

This is a large scale study involving fluoxetine (Prozac) versus a placebo in the treatment of adolescents with alcohol use disorder (AUD) and major depression (MDD). All individuals will receive treatment for 12 weeks with a followup phase lasting 9 months.

AlcoholismDepression

University of Pittsburgh50 participantsStarted Jul 2001

Pittsburgh, Pennsylvania, United States

WITHDRAWNPhase 3< 1 mile

Combination Chemotherapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer

NCT00054392

RATIONALE: Drugs used in chemotherapy such as gemcitabine, carboplatin, and paclitaxel use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. It is not yet known which chemotherapy regimen is more effective in treating non-small cell lung cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of different combination chemotherapy regimens in treating patients who have stage IIIB, stage IV, or recurrent non-small cell lung cancer.

Lung Cancer

Fox Chase Cancer CenterStarted Sep 2001

Loma Linda, California, United States • Pomona, California, United States • New London, Connecticut, United States +54 more locations

Pharmacological Intervention Project (Fluoxetine)

Combination Chemotherapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer

Find Trials by Condition in Pittsburgh

Efficacy and Safety of Adalimumab and Methotrexate (MTX) Versus MTX Monotherapy in Subjects With Early Rheumatoid Arthritis

Comparison of Aneuploidy Risk Evaluations

R115777 in Treating Patients With Progressive, Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

Safety and Dose Determining Study of BT062 in Patients With Relapsed or Refractory Multiple Myeloma

Genetic and Environmental Risk Assessment for Colorectal Cancer in Healthy Participants

Melphalan, Arsenic Trioxide, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma

Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) Taking Salmeterol Xinafoate/Fluticasone Propionate Combination

VNP40101M in Treating Patients With Acute Myelogenous Leukemia or High-Risk Myelodysplasia

Randomized Study of Sorafenib Dose Escalation in Patients With Previously Untreated Metastatic Renal Cell Carcinoma

Safety and Efficacy of NAB001 in the Treatment of Mild to Moderate Onychomycosis of the Toenails

Occipital Nerve Stimulation in the Treatment of Migraine

Forodesine (BCX-1777) in Treating Patients With Refractory Stage IIA, Stage IIB, Stage III, Stage IVA, or Stage IVB Cutaneous T-Cell Lymphoma

SU5416 in Treating Patients With Refractory or Relapsed Multiple Myeloma

Gemcitabine and Cisplatin in Treating Patients With Metastatic or Recurrent Solid Tumors

Monoclonal Antibody F19 in Treating Patients With Advanced or Metastatic Cancer

Soblidotin and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors

VNP40101M in Treating Patients With Advanced Solid Tumors or Lymphomas

3-Aminopyridine-2-carboxaldehyde Thiosemicarbazone in Treating Patients With Solid Tumors